Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Fidelity’s FMR holds 2.91 million Maisons du Monde shares, 0.36% stake

Fidelity’s FMR holds 2.91 million Maisons du Monde shares, 0.36% stake

ReutersReuters2026/08/14 11:06
  • FMR cut its stake in Maisons du Monde below the 5% threshold on June 3, 2026.
  • Holding stood at 3,199,037 shares, equal to 0.39% of share capital and voting rights.
  • Position fell to 2,912,403 shares, or 0.36%, as of Aug. 12, 2026.
  • Move reflected dilution from an increase in the company’s share count.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maisons du Monde SA published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well

Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.

智通财经2026/09/07 07:31
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well